Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 138   

Articles published

ABT 58.84 -0.01 (-0.02%)
price chart
Abbott Laboratories' (ABT) Management Presents at 36th Annual JPMorgan ...
As a result of our performance, last year, Kiplinger named Abbott one of the 30 best stocks of all time. The second milestone is the five year anniversary of our AbbVie separation.
Miles White's Bold Moves Made Abbott Laboratories A Global Force
When Miles White was named CEO of Abbott Laboratories (ABT) in 1998 at 43, he was the youngest head of a major health care company.
Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 11, 2018  Nasdaq
Abbott Laboratories (NYSE:ABT) Earns Media Impact Score of 0.19  The Ledger Gazette
Abbott touts new pain-relief device data
Two years after implant, patients who use Abbott Laboratories' implantable spinal cord stimulators for chronic pain continue to prefer the company's proprietary stimulation pattern over traditional stimulation, new study data show.
Abbott Labs Has 'An Emerging Picture Of Top-Tier Growth,' Says Morgan Stanley
... risk-reward reverses in 2018, Lewis said, helped by fading of the regulatory issues with St Jude Medical Inc (NYSE: STJ), Alere Inc (NYSE: ALR) returning to stable revenue in 2018, China Pediatric Nutrition resuming double-digit growth and the ...
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Looking at the universe of stocks we cover at Dividend Channel , on 1/11/18, Patterson Companies Inc (Symbol: PDCO), AbbVie Inc (Symbol: ABBV), and Abbott Laboratories (Symbol: ABT) will all trade ex-dividend for their respective upcoming dividends ...
Selle: With opioid suit, Nerheim takes jab at Abbott Labs
Abbott and Purdue Pharma are only two of the firms named in the lawsuits filed last week in Illinois. And, it's not the first time both have been sued over allegedly causing opioid addictions.
Medicare to cover new glucose monitor, giving Abbott an edge over rival Dexcom
Yet they saw limits from patients having to pay for it out-of-pocket while Abbott waited for coverage approval from insurance companies and the Centers for Medicare & Medicaid Services.
CMS to cover Abbott's glucose monitoring device  Reuters
Medicare patients with diabetes gain coverage for Abbott's prick-free ...  Chicago Tribune
Year-End Portfolio Pruning, Part 2: Abbott Labs: Buy The Rumor, Sell The News
On an absolute basis, Abbott Labs has rallied about 40% this year. The stock has a current PE of 45.75 and PEG ratio of 3.94; this is a very expensive issue.
Sector Gamma As Lowered Its Abbott Labs (ABT) Holding as Share Value Declined
Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It fall, as 47 investors sold ABT shares while 563 reduced holdings.
Comparing Valuation And Performance: Abbott Laboratories (ABT), Caterpillar ...  StockNewsGazette
What Do Analysts Think About Abbott Laboratories's (NYSE:ABT) Future?  Simply Wall St
Abbott shares gain after JP Morgan upgrades them to overweight
The analyst forecasts $68 million in sales in 2018, with upside up to about $100 million if Abbott secures either commercial reimbursement, Medicare reimbursement, or labeling for kids earlier than expected.